Health Highlights: Nov. 1, 2016

By on November 1, 2016

Here are some of the latest health and medical news developments, compiled by the editors of HealthDay:

Two New Genetically-Engineered Potato Varieties Approved by USDA

Two new types of genetically-engineered potatoes resistant to the disease that caused the Irish potato famine have been approved by the U.S. Department of Agriculture.

The Ranger Russet and Atlantic varieties of Innate potatoes were created by J.R. Simplot Co. of Idaho, the Associated Press reported.

The potatoes are resistant to late blight, which caused the Irish potato famine. They contain only potato genes and their resistance to late blight comes from an Argentinian variety of potato that has natural resistance to the disease.

Late blight is still a major challenge for potato growers worldwide, especially in wetter regions, the AP reported.

The two new varieties are also less prone to bruising and black spots, store better, and have lower levels of a potentially cancer-causing chemical created when potatoes are cooked at high temperatures.

The new potatoes must still undergo a voluntary review process through the Food and Drug Administration and get approval from the U.S. Environmental Protection Agency. Simplot said it expects those approvals in January, with sales of the potatoes starting next spring, the AP reported.

A third variety of potato called the Russet Burbank has the same traits and was previously approved by the USDA and FDA, with EPA approval also expected in January.

While there is no evidence that genetically-modified foods are unsafe to eat, some consumers are wary of them, the AP reported.

Leave a Reply

Your email address will not be published. Required fields are marked *